Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Inhibition of human fXIIA by fluorescence based analysis
Assay data:1 Tested
SummaryPubMed CitationRelated BioAssays by Target
Inhibition of human fXA by fluorescence based analysis
Inhibition of human trypsin by fluorescence based analysis
Inhibition of human thrombin by fluorescence based analysis
Inhibition of human plasmin by fluorescence based analysis
Assay data:1 Active, 1 Tested
SummaryCompounds, ActivePubMed CitationRelated BioAssays by Target
Inhibition of human KLK1 using H-DVal-Leu-Arg-AFC as substrate
Assay data:3 Active, 1 Activity ≤ 1 µM, 5 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by Target
Inhibition of human plasma kallikrein using H-DPro-Phe-Arg-AFC as substrate
Assay data:8 Active, 1 Activity ≤ 1 nM, 7 Activity ≤ 1 µM, 8 Tested
Inhibition of fXIIa (unknown origin)
Assay data:2 Tested
Inhibition of thrombin (unknown origin)
Assay data:5 Tested
Inhibition of plasmin (unknown origin)
Assay data:1 Active, 2 Activity ≤ 1 µM, 8 Tested
Inhibition of plasma kallikrein (unknown origin)
Assay data:13 Active, 11 Activity ≤ 1 µM, 17 Tested
Enzymatic Activity Assay from US Patent US9512065: "Polymorphs of N-[(R)-1-[(S)-1-(4-aminomethyl-benzylcarbamoyl)-2-phenyl-ethylcarbamoyl]-2-(4-ethoxy-phenyl)-ethyl]-benzamide hydrochloride"
SummaryCompounds, ActiveRelated BioAssays by Target
Enzyme Assay from US Patent US9234000: "Benzylamine derivatives as inhibitors of plasma kallikrein"
Assay data:1 Active, 26 Tested
SummaryCompounds, ActiveRelated BioAssays by DepositorRelated BioAssays by Target
In Vitro Inhibition Assay from US Patent US9234000: "Benzylamine derivatives as inhibitors of plasma kallikrein"
Assay data:48 Active, 6 Activity ≤ 1 µM, 181 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by DepositorRelated BioAssays by Target
Assay data:184 Active, 150 Activity ≤ 1 µM, 198 Tested
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on